Science Explorer Back to mapMap
Discussion
Researcher · Idera Pharmaceuticals (United States) · United States

Cyril B. Dousson

Cyril B. Dousson publishes mostly in Organic Chemistry, Epidemiology and Hepatology, on topics such as HIV/AIDS drug development and treatment, Hepatitis C virus research and Asymmetric Hydrogenation and Catalysis.

ORCID 0000-0002-6046-5032 OpenAlex
World rank
#2,816,397
of 7,710,434 ranked researchers
Rank in United States
#816,433
of 1,627,098
Works
26
Citations
857
Citations per work
33.0
h-index
11
i10-index 12Top 57% in Organic Chemistry
Cyril B. Dousson

What does Cyril B. Dousson research?

Cyril B. Dousson's work is mostly in Medicine (37%), Chemistry (31%), Biochemistry, Genetics and Molecular Biology (9%).

Health Sciences: 10 works · 36.8% of their workMedicine: 10 works · 36.8% of their workEpidemiology: 3 works · 13.2% of their workHepatology: 3 works · 11.8% of their workInfectious Diseases: 3 works · 11.8% of their workPhysical Sciences: 8 works · 30.9% of their workChemistry: 8 works · 30.9% of their workOrganic Chemistry: 6 works · 22.1% of their workInorganic Chemistry: 2 works · 8.8% of their workEverything else: 6 works · 23.5% of their workLife Sciences: 2 works · 8.8% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 8.8% of their workMolecular Biology: 2 works · 8.8% of their workTHEIR WORKCyril B. Dousson26works
Life Sciences9%Physical Sciences31%Health Sciences37%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1036.8%
    1. Chemistry830.9%
  3. Everything else623.5%
    1. Biochemistry, Genetics and Molecular Biology28.8%
  1. 1Organic Chemistry22% of their works
  2. 2Epidemiology13% of their works
  3. 3Hepatology12% of their works
  4. 4Infectious Diseases12% of their works
  5. 5Molecular Biology9% of their works
  6. 6Inorganic Chemistry9% of their works

Research topics

Which keywords describe Cyril B. Dousson's research?

The keywords of their largest research topics: Antiviral Therapy, Liver Disease, Enantioselective Reactions, Antiretroviral Therapy, HIV Infection, Hepatitis C Virus, Treatment and Asymmetric Catalysis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Antiviral Therapy112 topics
  2. Liver Disease112 topics
  3. Enantioselective Reactions92 topics
  4. Antiretroviral Therapy81 topic
  5. HIV Infection81 topic
  6. Hepatitis C Virus71 topic
  7. Treatment71 topic
  8. Asymmetric Catalysis61 topic
  9. Hydrogenation61 topic
  10. Chronic Hepatitis B41 topic
  11. Enzyme Regulation41 topic
  12. Hepatitis B Virus41 topic
  13. Nucleotide Metabolism41 topic
  14. Organophosphorus Synthesis41 topic
  15. Phosphonate Chemistry41 topic
  16. Chiral Catalysts31 topic
  17. Organocatalysis31 topic
  18. Cell Division21 topic
  19. Microtubules21 topic

Where does Cyril B. Dousson work?

Cyril B. Dousson's main affiliation in the publication record is Idera Pharmaceuticals (United States), United States.

How many publications and citations does Cyril B. Dousson have?

OpenAlex counts 26 works and 857 citations for Cyril B. Dousson, an h-index of 11, ranking #2,816,397 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Cyril B. Dousson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.